Syneron Bio Announces Strategic Collaboration with AstraZeneca
Press Releases
Syneron Bio  
March 21, 2025

Syneron Bio Announces Strategic Collaboration with AstraZeneca

BEIJING, March 21, 2025 /PRNewswire/ -- Syneron Bio, a cutting-edge oral macrocyclic peptide drug biotech company, announced today a strategic collaboration with the global biopharmaceutical leader AstraZeneca to develop potential

avatar profile Olean Times Herald

Olean Times Herald


Local & Social